ArticleInternational journal of molecular sciences2022

Sunitinib versus Pazopanib Dilemma in Renal Cell Carcinoma: New Insights into the In Vitro Metabolic Impact, Efficacy, and Safety.

Filipa Amaro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.